• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM26A
Device Problem Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/04/2023
Event Type  malfunction  
Event Description
As reported by an edwards lifesciences affiliate, regarding a 26mm sapien 3 ultra resilia valve in the aortic position.During valve deployment the 26mm commander delivery system balloon ruptured after 1-2 seconds of fill deployment.The commander balloon was removed from the patient without incident or complication from the esheath.After a replay of the fluoroscopy imaging during deployment, the implanting physicians surmised that calcium at the level of the stj most likely initiated balloon rupture as evidence of rupture as the precise point at the shoulder of the balloon made contact with the calcium stj lesion.After imaging review, the implanting physicians determined the valve to be fully deployed.Post-assessment of the deployed valve showed no pv leak and a mean gradient of 4 mmhg via tte.Implanting physicians concluded that post-dilation of the deployed valve was unnecessary, given the fluoroscopic and post-deployment clinical assessments.
 
Manufacturer Narrative
Investigation is underway.H3 other text : not returned.
 
Manufacturer Narrative
The event reported is anticipated in the risk management documentation for transcatheter heart valve procedures.A previous investigation into this type of event is captured in an edwards lifesciences technical summary and applies to this complaint.Additional assessment of the failure mode is not required at this time.The device was returned for evaluation.The returned delivery system was visually evaluated, and the following was observed: balloon is burst longitudinally.Due to the condition of the returned device (e.G., balloon burst), no functional testing was able to be performed.Dimensional testing was performed.The inflation balloon single wall thickness was measured along the edges of the burst location and all measurements met specification.Per the technical summary, the ifu, current risk mitigations include design and manufacturing controls, and training manuals have been reviewed, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported event was confirmed based on the returned product evaluation.Available information suggests patient factors (calcification) likely contributed to the event as the event description stated, calcium at the level of the stj most likely initiated balloon rupture as evidence of rupture as the precise point at the shoulder of the balloon made contact with the calcium stj lesion.The presence of calcification can create a challenging anatomy for balloon inflation.While the balloons are sufficiently designed and tested to ensure the burst pressure is at or above the rated burst pressure, calcified nodules can compromise the structure of the balloon wall via following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no edwards product defects or labeling deficiencies were identified, no corrective or preventative action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506384
MDR Report Key18361089
MDR Text Key331190558
Report Number2015691-2023-18564
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103207835
UDI-Public(01)00690103207835(17)250618(10)65143607
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750CM26A
Device Lot Number65143607
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/19/2023
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-